مقاله‌های دارای تعهدات انتشار عمومی - Frank Furnariبیشتر بدانید
جای دیگری دردسترس نیست: یک
Retracted: PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors
SR Ferdosi, B Taylor, M Lee, N Tang, S Peng, R Bybee, G Reid, ...
Neuro-oncology 24 (11), 1857-1868, 2022
تعهدات: US National Institutes of Health
جای دیگری دردسترس است: ۹۸
Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
KM Turner, V Deshpande, D Beyter, T Koga, J Rusert, C Lee, B Li, ...
Nature 543 (7643), 122-125, 2017
تعهدات: US National Science Foundation, US National Institutes of Health, Susan G. Komen
Emerging insights into the molecular and cellular basis of glioblastoma
GP Dunn, ML Rinne, J Wykosky, G Genovese, SN Quayle, IF Dunn, ...
Genes & development 26 (8), 756-784, 2012
تعهدات: US National Institutes of Health
Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA
DA Nathanson, B Gini, J Mottahedeh, K Visnyei, T Koga, G Gomez, ...
Science 343 (6166), 72-76, 2014
تعهدات: US National Institutes of Health
Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma
R Bonavia, A Mukasa, Y Narita, DWY Sah, S Vandenberg, C Brennan, ...
Genes & development 24 (16), 1731-1745, 2010
تعهدات: US National Institutes of Health
Heterogeneity maintenance in glioblastoma: a social network
R Bonavia, MM Inda, WK Cavenee, FB Furnari
Cancer research 71 (12), 4055-4060, 2011
تعهدات: US National Institutes of Health, Government of Spain
Circular ecDNA promotes accessible chromatin and high oncogene expression
S Wu, KM Turner, N Nguyen, R Raviram, M Erb, J Santini, J Luebeck, ...
Nature 575 (7784), 699-703, 2019
تعهدات: US National Science Foundation, US National Institutes of Health, Howard …
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
FB Furnari, TF Cloughesy, WK Cavenee, PS Mischel
Nature Reviews Cancer 15 (5), 302-310, 2015
تعهدات: US National Institutes of Health
Cancer-associated protein kinase C mutations reveal kinase’s role as tumor suppressor
CE Antal, AM Hudson, E Kang, C Zanca, C Wirth, NL Stephenson, ...
Cell 160 (3), 489-502, 2015
تعهدات: US National Institutes of Health, Cancer Research UK
EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma
B Mukherjee, B McEllin, CV Camacho, N Tomimatsu, S Sirasanagandala, ...
Cancer research 69 (10), 4252-4259, 2009
تعهدات: US National Institutes of Health
Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance
T E Taylor, F B Furnari, W K Cavenee
Current cancer drug targets 12 (3), 197-209, 2012
تعهدات: US National Institutes of Health
An LXR-cholesterol axis creates a metabolic co-dependency for brain cancers
GR Villa, JJ Hulce, C Zanca, J Bi, S Ikegami, GL Cahill, Y Gu, KM Lum, ...
Cancer cell 30 (5), 683-693, 2016
تعهدات: US National Institutes of Health
A Drosophila Model for EGFR-Ras and PI3K-Dependent Human Glioma
RD Read, WK Cavenee, FB Furnari, JB Thomas
PLoS genetics 5 (2), e1000374, 2009
تعهدات: US National Institutes of Health
NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling
S Chowdhry, C Zanca, U Rajkumar, T Koga, Y Diao, R Raviram, F Liu, ...
Nature 569 (7757), 570-575, 2019
تعهدات: US National Science Foundation, US National Institutes of Health
EGFR mutation promotes glioblastoma through epigenome and transcription factor network remodeling
F Liu, GC Hon, GR Villa, KM Turner, S Ikegami, H Yang, Z Ye, B Li, ...
Molecular cell 60 (2), 307-318, 2015
تعهدات: US National Institutes of Health
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
R Bonavia, MM Inda, S Vandenberg, SY Cheng, M Nagane, P Hadwiger, ...
Oncogene 31 (36), 4054-4066, 2012
تعهدات: US National Institutes of Health, Government of Spain
Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients
KV Lu, S Zhu, A Cvrljevic, TT Huang, S Sarkaria, D Ahkavan, J Dang, ...
Cancer research 69 (17), 6889-6898, 2009
تعهدات: US National Institutes of Health
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma
FI Staquicini, MG Ozawa, CA Moya, WHP Driessen, EM Barbu, ...
The Journal of clinical investigation 121 (1), 161-173, 2011
تعهدات: US National Institutes of Health
Oncogene amplification in growth factor signaling pathways renders cancers dependent on membrane lipid remodeling
J Bi, TA Ichu, C Zanca, H Yang, W Zhang, Y Gu, S Chowdhry, A Reed, ...
Cell metabolism 30 (3), 525-538. e8, 2019
تعهدات: US National Institutes of Health
Epidermal growth factor receptor extracellular domain mutations in glioblastoma present opportunities for clinical imaging and therapeutic development
ZA Binder, AH Thorne, S Bakas, EP Wileyto, M Bilello, H Akbari, ...
Cancer cell 34 (1), 163-177. e7, 2018
تعهدات: US National Institutes of Health, National Health and Medical Research …
اطلاعات انتشارات و تأمین بودجه به‌طورخودکار توسط برنامه رایانه‌ای تعیین می‌شود.